Anne Wagner, PhD, C.Psych
Dr. Anne Wagner is the founder of Remedy, a centre for mental health innovation committed to clinical practice, research, and community-building, based in Toronto, Ontario. Dr. Wagner uses her training in MDMA-assisted psychotherapy, cognitive-behavioural and mindfulness-based approaches in helping individuals, couples, and others in intimate relationships to process trauma, navigate their lives, and prepare for and integrate experiences in psychedelic and non-ordinary states of consciousness. She is one of the investigators of the MAPS-sponsored pilot trial of Cognitive-Behavioral Conjoint Therapy for PTSD + MDMA, studying the impact of treating couples where one member is diagnosed with PTSD. She is the Principal Investigator for the upcoming randomized trial of CBCT + MDMA, as well as for a pilot trial of Cognitive Processing Therapy + MDMA for PTSD. She sits on the Board of Directors of Casey House, Toronto’s HIV/AIDS hospital, and is also an adjunct professor at Ryerson University. Learn more about Anne on her profile in the Psychedelic.Support Network or at Remedy.